CHCT: the cash flow

MyFinsight

For the year ending 2025-12-31, CHCT had -$1,044K decrease in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Net income (loss)	5,102
Depreciation and amortization	43,538
Other amortization	1,330
Stock-based compensation	10,305
Accelerated amortization of stock-based compensation	4,591
Straight-line rent receivables	3,721
(gains) on the sales of depreciable real estate assets, net of losses and impairments	11,803
Credit loss reserve	8,672
Net gain from insurance recovery on casualty loss	0
Deferred income tax expense	23
Other assets	-994
Accounts payable and accrued liabilities	-1,219
Other liabilities	-1,382
Net cash provided by operating activities	56,430
Acquisitions of real estate	64,599
Proceeds from the sale of real estate	32,202
Funding of notes receivable	0
Proceeds from repayments on notes receivable	5,225
Insurance proceeds from casualty loss	0
Capital expenditures on existing real estate properties	20,524
Net cash used in investing activities	-47,696
Net borrowings on revolving credit facility	46,000
Term loan repayments	0
Mortgage note repayments	0
Dividends paid	53,669
Proceeds from issuance of common stock	0
Taxes paid on behalf of employees and shares withheld upon shares vesting	1,792
Equity issuance costs	317
Debt issuance costs	0
Net cash (used in) provided by financing activities	-9,778
Decrease in cash, cash equivalents and restricted cash	-1,044
Cash and cash equivalents at beginning of period	4,384
Cash and cash equivalents at end of period	3,340

Unit: Thousand (K) dollars (except for numbers of shares and EPS).